Okay, let's tackle this question about apoptosis. The question is asking which enzyme is responsible for destroying the nucleus during apoptosis. First, I need to recall the key players in the apoptotic process.

Apoptosis involves a cascade of caspases, which are proteases that cleave specific cellular substrates. The execution phase includes the activation of caspases like caspase-3, which then activate other enzymes. One of the key enzymes in degrading DNA is DNase. Specifically, DNase gamma or CAD (Caspase-Activated DNase) comes to mind. I think CAD is the one that's responsible for DNA fragmentation.

Now, the nucleus is the target here. When cells undergo apoptosis, the nuclear envelope breaks down, and the DNA is fragmented. CAD is activated by caspase-3, which is part of the executioner caspases. So the correct answer should be CAD.

Looking at the options, I need to check if they include CAD. The other options might be other enzymes like endonucleases or proteases. For example, endonucleases could be involved in other processes, but not specifically in apoptosis. Proteases like caspases-3 are activators but don't directly destroy the nucleus. DNAse II is another enzyme, but I'm not sure if it's involved in apoptosis.

So, the main point is that CAD, once activated, translocates to the nucleus and degrades DNA. That's why the nucleus is destroyed in apoptosis. The other options are either activators or involved in different processes. The clinical pearl here is that CAD's role in apoptosis is a key exam topic, often paired with caspase-3 activation.

**Core Concept**
Apoptosis involves programmed cell death orchestrated by caspase-activated nucleases, with the nucleus undergoing DNA fragmentation via endonucleolytic cleavage. The key enzyme responsible for nuclear destruction is **caspase-activated DNase (CAD)**, which is sequestered by its inhibitor (ICAD) until caspase-3 cleaves ICAD during apoptosis.

**Why the Correct Answer is Right**
Caspase-3, an executioner caspase, cleaves its inhibitor (ICAD), releasing active CAD (caspase-activated DNase). CAD translocates to the nucleus and degrades genomic DNA into nucleosome-sized fragments, a hallmark of apoptosis. This process is tightly regulated and distinct from necrosis, where passive DNA damage occurs. The nuclear envelope disintegrates, allowing CAD access to chromatin.

**Why Each Wrong Option is Incorrect**
**Option A:** *DNAse II* is primarily involved in autophagy and lysosomal DNA degradation, not apoptosis.
**Option B:** *Endonuclease G* is localized in mitochondria and contributes to apoptosis but acts after mitochondrial release, not directly on the nucleus.
**Option C:** *Protease-activated receptor-1 (PAR-1)* is a G-protein-coupled receptor involved in thrombin signaling, unrelated to nuclear degradation.

**Clinical Pearl / High-Yield Fact**
Remember the cascade: **Caspase-3 → ICAD cleavage → CAD activation → Nuclear DNA fragmentation**. This pathway is a hallmark of apoptosis and a common exam target. Distinguish CAD from other nucleases like Endonuclease G (

✓ Correct Answer: A. Endonuclease fragmentation